Top 5 Companies Advertising in Professional Health Journals (Dollars) in Q1 2013

by Client Services

Through the first quarter of 2013, Johnson & Johnson Corporate ($8 MM) is the top pharma company advertising in professional health journals by dollars, a 31% increase year-over-year, according to Kantar Media. Other companies making big investments in print journal advertising are as follows:

Top 5 Print Ad Pharma Companies (Dollars): Jan. – Mar. 2013

#1 Johnson & Johnson Corporate – $8 MM (+32%)

#2 Forest Laboratories – $6 MM (-64%)

#3 Ironwood Pharmaceutical and Forest Pharmaceuticals – $4 MM (N/A)

#4 Pfizer Corporate – $3 MM (-11%)

#5 Novo Nordisk Pharmaceutical – $2 MM (-14%)

Novo Nordisk didn’t make the top 5 companies at the end of last month – the company’s advertising this year primarily focuses on diabetes care, specifically for the product Victoza, an injectable medication that may help improve blood sugar levels in adults with type 2 diabetes, as well as their DM² commitment to diabetes education.

Forest and Ironwood entered a partnership in 2007 in the development of the product Linzess, which was approved in 2012.  The companies have spent about $4 million so far this year advertising the product. Forest has also spent almost $4 million advertising Tudorza in Q1 2013.

The percentage changes compare Q1 2013 to Q1 2012. For more information on these ad insights or other data, let one of us know.

Kantar Media sets the standard for accurate, comprehensive competitive advertising intelligence in the professional healthcare arena. Check back next month for updated data on the top products, classes, companies and category movers year-to-date.